Henrik Lund
Director/Board Member at Oslo Cancer Cluster NCE
Profile
Henrik Lund is currently the Director at Oslo Cancer Cluster NCE and MedCoast Scandinavia.
Previously, he was the Chief Executive Officer and Head-Investor Relations at NEL ASA in 2012 and the CEO and Investor Relations Officer at Bionor Pharma ASA in 2011.
Henrik Lund active positions
Companies | Position | Start |
---|---|---|
Oslo Cancer Cluster NCE
Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Director/Board Member | 2011-06-16 |
MedCoast Scandinavia | Director/Board Member | 2011-06-16 |
Former positions of Henrik Lund
Companies | Position | End |
---|---|---|
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | President | 2011-08-14 |
NEL ASA | Chairman | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NEL ASA | Producer Manufacturing |
Private companies | 3 |
---|---|
Oslo Cancer Cluster NCE
Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Commercial Services |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
MedCoast Scandinavia |
- Stock Market
- Insiders
- Henrik Lund